English
  • All
  • Products
  • News
  • Manuals
  • Instruments
  • News
    Company News
    2022.08.18
    Congratulations! Clongene COVID-19 Antigen Rapid Tests have passed SARS-CoV-2 variants validation by TGA
    The TGA is reviewing all COVID-19-specific laboratory antigen tests and rapid antigen tests (RATs), including point-of-care and self-tests, included in the Australian Register of Therapeutic Goods (ARTG). The purpose of the review is to determine if tests have been impacted ...
    More
    2022.07.28
    2022 AACC ended successfully
    July 28, 2022, AACC ended successfully in Chicago which can function like a lens to focus our attention on emerging science and clinical developments that are of contemporary importance.Clongene brought main products, such as infectious diseases, drugs of abuse, COVID-19 Ant...
    More
    2022.04.27
    Clungene COVID-19 Antigen Rapid Test has obtained CE certification
    In February 2022, CLUNGENE®COVID-19 Antigen Rapid Test for self-testing manufactured by Clongene has obtained the CE certification in EU. Our self-testing product can be sold in the European Union and other countries that recognize the CE certification.CLUNGENE®COVID-19 Anti...
    More
    2022.04.27
    Clungene COVID-19 Antigen Rapid Test Products Obtained TGA Certification in Australia
    “Clungene COVID-19 Antigen Rapid Test for self-testing” and “Clungene COVID-19 Antigen Rapid Test” manufactured by Clongene have obtained the TGA Certification in Australia on January 7, 2022. The certifications indicate that the Clungene COVID-19 Antigen Rapid Test products...
    More
    2022.04.27
    Good News! Clongene is on the Recognized List of Rapid Antigen Tests by the EU
    On 21 January 2021, Member States unanimouslyagreed on a Council recommendation setting a common frameworkfor the use of rapid antigen tests and the mutual recognition of COVID-19 test results across the EU.The products need to meet the following requirements:(a)Carry CE mar...
    More
     1 2